About Vivitra 440mg Injection
Spotlight on efficacy and value, Vivitra 440mg Injection offers a lofty advance in oncology, harnessing the ineffable power of monoclonal antibody therapy. Marketed by Zydus Oncosciences, this ravishing single-use vial contains Trastuzumab (440mg) in a lyophilized, odorless powder, quick to reconstitute and administer intravenously. Explored for treating HER2-positive breast and metastatic gastric cancers, Vivitra stands out for its remarkable compatibility and tailored formulation. Designed for prescription-for-hospital use, its stable composition ensures a shelf life of 24 months at controlled temperatures. Discover the difference with Vivitra.
Vivitra 440mg: Application Surface and Features
Vivitra 440mg Injection is specifically applied in hospital settings and is used for patients diagnosed with HER2-positive breast cancer as well as metastatic gastric cancer. This biosimilar trastuzumab, in an easy-to-reconstitute lyophilized powder form, serves as a critical tool in modern cancer therapy. Ineffably designed for intravenous administration, its features include high compatibility, odorless composition, and precise strength, making it an invaluable asset for healthcare professionals and patients seeking targeted, efficient treatment solutions.
Vivitra 440mg: Packaging Details and Export Information
Vivitra 440mg comes in a secure vial packaging with a solvent for reconstitution to ensure stability and safety during transit and storage. Stock is ready for shipment throughout major export markets, with India as the primary FOB port. Rates are structured to deliver optimal value, minimizing expenditure for healthcare providers. Each vial is individually sealed to maintain shelf life and efficacy, meeting rigorous export standards and guaranteeing reliable supply for international pharmaceutical traders and suppliers.
FAQ's of Vivitra 440mg Injection:
Q: How is Vivitra 440mg Injection administered?
A: Vivitra 440mg Injection is administered intravenously and must be diluted using the provided solvent before use. It should only be prepared and given by qualified medical professionals in a hospital setting.
Q: What are the primary medical uses for Vivitra 440mg Injection?
A: Vivitra 440mg Injection is used mainly in the treatment of HER2-positive breast cancer and metastatic gastric cancer, offering targeted monoclonal antibody therapy to improve patient outcomes.
Q: When should Vivitra 440mg Injection be stored, and under what conditions?
A: Vivitra 440mg Injection should be stored at temperatures between 2C to 8C. It is essential not to freeze the product to preserve its effectiveness and shelf life, which extends up to 24 months from the manufacturing date.
Q: What is the process for reconstituting Vivitra before administration?
A: Vivitra 440mg must be reconstituted with the provided solvent prior to intravenous administration. The reconstitution and dilution should be carried out in accordance with the instructions provided to maintain the medication's integrity and efficacy.
Q: Where can Vivitra 440mg Injection be procured?
A: Vivitra 440mg Injection is available through hospitals, authorized suppliers, and pharmaceutical traders, especially in India and other global export markets. A valid prescription is required for procurement and administration.